REFERENCES
- Lin S, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001;32:358–366.
- Denning DW. Invasive aspergillosis. Clin Infect Dis 1998;26:781–805.
- Komi M, Hon A, Takaue Y, Mutou Y. The gastrointestinal tract is a common target of invasive aspergillosis in patients receiving cytotoxic chemotherapy for haematological malig-nancy. Clin Infect Dis 2002;35:105–107.
- Meyer RD, Young LS, Armstrong D, Yu B. Aspergillosis complicating neoplastic disease. Am J Med 1973;54:6–15.
- Young RC, Bennett JE, Vogel CL, Carbone PP, DaVita VT. Aspergillosis: the spectrum of disease in 98 patients. Medicine 1970;49: 147–173.
- Gercovich FG, Richman SP, Rodriguez V, Luna M, McCre-die KB, Bodey GP. Successful control of systemic Aspergillus Niger infections in two patients with acute leukemia. Cancer 1975;36:2271–2276.
- Denning DW. Therapeutic outcome in invasive aspergillosis. Clin Infect Dis 1996;23:608–615.
- Schaffner A, Douglas H, Braude A. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus: observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J Clin Invest 1982;69: 617–631.
- Diamond RD, Krzesicki R, Epstein B, Jao W. Damage to hyphal forms of fungi by human leukocytes in vitro: a possible host defense mechanism in aspergillosis and mucormycosis. Am J Pathol 1978;91:313–328.
- Roilides E, Holmes A, Blake C, Venzon D, Pizzo PA, Walsh TJ. Antifungal activity of elutriated human monocytes against Aspergillus fumigatus hyphae: enhancement by granulocyte-macrophage colony-stimulating factor and interferon-gamma. J Infect Dis 1994;170:894–899.
- Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966;64:328.
- Gerson SL, Talbot GH, Hurwitz S, Strom BL, Lusk EJ, Cassileth PA. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med 1984;100:345–351.
- Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consen-sus. Clin Infect Dis 2002;34:7–14.
- Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann J et al. Voriconazole versus amphoter-icin B for primary therapy of invasive aspergillosis. N Engl J Med 2002;347:408–415.